Traders should monitor for potential restatements, delayed filings, or further auditor changes. The combination of a Big 4 auditor dismissal, going concern warning, and material weaknesses significantly increases financial and operational risk. Consider downside exposure given the company's $3M market cap and sector mismatch (biotech name but classified as crude petroleum).
Price Chart
Executive Summary
Arcadia Biosciences (RKDA) dismissed Deloitte & Touche LLP as its independent auditor and appointed Ramirez Jimenez International CPAs (RJI) as successor. The change follows disclosure of material weaknesses in internal controls and a going concern qualification in Deloitte's audit report. Deloitte confirmed agreement with the filing's disclosures.
Key Facts
- Deloitte & Touche LLP was dismissed as Arcadia's auditor on March 30, 2026
- Ramirez Jimenez International CPAs (RJI) was engaged as the new auditor
- Deloitte's audit reports included a going concern qualification due to accumulated deficit, recurring losses, and insufficient cash resources
- Material weaknesses in internal control were disclosed, including insufficient segregation of duties and IT controls due to reduced headcount
- No disagreements or reportable events other than the material weaknesses were reported
- Deloitte provided a letter agreeing with the company's disclosures in the 8-K
Financial Impact
High risk of financial instability due to going concern qualification and material internal control weaknesses
Risk Factors
- Going concern qualification indicates substantial doubt about the company's ability to continue operations
- Material weaknesses in internal controls increase risk of financial misstatement
- Change from Big 4 (Deloitte) to a smaller firm (RJI) may signal reduced audit capacity or credibility
- Potential for future restatements or filing delays
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-142030 |
| Document: 0001193125-26-142030-index.html | 0001193125-26-142030 |
| Document: 0001193125-26-142030.txt | 0001193125-26-142030 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | SC 13G | $0.2800 | awaiting T+60 | — | $0.1518 (−45.79%) |
Sep 15, 2026 5w ago | 8-K | $0.4310 | awaiting T+60 | — | $0.1518 (−64.78%) |
Jul 9, 2026 15w ago | EFFECT | $0.6755 $0.2882 | ▲ +57.34% | ▲ +58.97% | $0.1518 (+77.53%) |
Jul 2, 2026 16w ago | 8-K | $0.7330 $0.3080 | ▼ −57.98% | ▼ −61.55% | $0.1518 (−79.29%) |
Jun 26, 2026 17w ago | S-3 | $0.7190 $0.4480 | ▲ +37.69% | ▲ +42.08% | $0.1518 (+78.89%) |
Jun 15, 2026 19w ago | 8-K | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1518 (+83.47%) |
Jun 12, 2026 19w ago | Press Release | $0.9183 $0.4797 | ▲ +47.76% | ▲ +48.77% | $0.1518 (+83.47%) |
Jun 12, 2026 19w ago | Press Release | $0.9180 $0.4530 | ▲ +50.65% | ▲ +51.31% | $0.1518 (+83.46%) |
May 14, 2026 23w ago | 8-K | $0.9560 $0.6699 | ▲ +29.93% | ▲ +34.44% | $0.1518 (+84.12%) |
Apr 30, 2026 25w ago | 10-K/A | $1.12 $0.6300 | ▼ −43.75% | ▼ −46.82% | $0.1518 (−86.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers